Keywords: serono, ready, acquisition, trial, turns, first-quarter, profit
Serono ready for acquisition trial as it turns in a first-quarter profit
Article | 01 May 2006
Europe's leading biotechnology company Serono, which has just taken itself off the selling-block, is now keen to make acquisitions instead. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
